| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.0033 | 1 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |